Home Search Top 10 Trends Watchlist Advertise Feedback Profile



ASX:NEU — Live Chart, Financials & Chat | NEUREN PHARMACEUTICALS LIMITED

N Neuren Pharmaceuticals Limited

ASX:NEU Australia

Revenue: 216.8m

$0.0/sec
Add to Watchlist
by TradingView


NEUREN PHARMACEUTICALS LIMITED Chat

C
Captainstonks 2y

#ASX:NEU Neuren Pharmaceuticals and Acadia Partner to Expand Global License for Trofinetide (DAYBUE™)

Neuren Pharmaceuticals and Acadia Partner to Expand Global License for Trofinetide (DAYBUE™)
Reply